Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Waterboer

Showing results (231-240 of 431) with videos related to

Pageof 44
Sort By:
BMC Infectious Diseases|December 5, 2018
Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) studySebastiaan H Hulstein, Amy Matser, Catharina J Alberts, et al.
Infectious Agents and Cancer|October 21, 2015
Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinomaShalaka S Hampras, Angelika Michel, Markus Schmitt, et al.
NPJ Vaccines|August 13, 2024
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort studyPenelope Gray, Filipe Colaço Mariz, Carina Eklund, et al.
Infectious Agents and Cancer|March 30, 2022
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African womenMwiza Gideon Singini, Elvira Singh, Debbie Bradshaw, et al.
The Journal of Experimental Medicine|May 16, 2020
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cellsGeorgina Bowyer, Hannah Sharpe, Navin Venkatraman, et al.
Viruses|April 30, 2021
From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 ProteomeJulia Butt, Rajagopal Murugan, Theresa Hippchen, et al.
International Journal of Cancer|June 1, 2024
Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex familiesWan-Lun Hsu, Jun Tao, Sheng Fu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 6, 2023
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damageDaniel Jons, Viktor Grut, Tomas Bergström, et al.
Plos One|December 28, 2018
Validation of Multiplex Serology detecting human herpesviruses 1-5Nicole Brenner, Alexander J Mentzer, Julia Butt, et al.
Frontiers in Immunology|August 14, 2025
AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cellsValentino D'Onofrio, Ana Carolina Santana, Marthe Pauwels, et al.
Pageof 44

Showing results (231-240 of 431) with videos related to

Sort By:
Pageof 44
BMC Infectious Diseases|December 5, 2018
Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) studySebastiaan H Hulstein, Amy Matser, Catharina J Alberts, et al.
Infectious Agents and Cancer|October 21, 2015
Merkel cell polyomavirus (MCV) T-antigen seroreactivity, MCV DNA in eyebrow hairs, and squamous cell carcinomaShalaka S Hampras, Angelika Michel, Markus Schmitt, et al.
NPJ Vaccines|August 13, 2024
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort studyPenelope Gray, Filipe Colaço Mariz, Carina Eklund, et al.
Infectious Agents and Cancer|March 30, 2022
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African womenMwiza Gideon Singini, Elvira Singh, Debbie Bradshaw, et al.
The Journal of Experimental Medicine|May 16, 2020
Reduced Ebola vaccine responses in CMV+ young adults is associated with expansion of CD57+KLRG1+ T cellsGeorgina Bowyer, Hannah Sharpe, Navin Venkatraman, et al.
Viruses|April 30, 2021
From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 ProteomeJulia Butt, Rajagopal Murugan, Theresa Hippchen, et al.
International Journal of Cancer|June 1, 2024
Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex familiesWan-Lun Hsu, Jun Tao, Sheng Fu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 6, 2023
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damageDaniel Jons, Viktor Grut, Tomas Bergström, et al.
Plos One|December 28, 2018
Validation of Multiplex Serology detecting human herpesviruses 1-5Nicole Brenner, Alexander J Mentzer, Julia Butt, et al.
Frontiers in Immunology|August 14, 2025
AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cellsValentino D'Onofrio, Ana Carolina Santana, Marthe Pauwels, et al.
Pageof 44